Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis.

scientific article published in February 2006

Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1191/135248506MS1227OA
P698PubMed publication ID16459723
P5875ResearchGate publication ID7313997

P50authorAldo QuattroneQ56862866
Paolo GirlandaQ57035158
Patrizio PasqualettiQ40032361
Maria TrojanoQ41721876
Alessandra LugaresiQ41721881
Ugo NocentiniQ46133541
Maria Fara De CaroQ47504485
Giuseppe SalemiQ47504554
P2093author name stringG Tedeschi
P Valentino
G Savettieri
D Farina
C Caltagirone
S Bonavita
A Reggio
F Le Pira
M Buccafusca
P2860cites workPulsed methylprednisolone induces a reversible impairment of memory in patients with relapsing-remitting multiple sclerosis.Q50875866
Changes of attention and memory in a group of patients with multiple sclerosis.Q51954309
Automatic and controlled information processing in multiple sclerosis.Q52022827
Information processing speed in patients with multiple sclerosis.Q52064788
Validity of some neuropsychological tests in the assessment of mental deteriorationQ52106915
Cognitive disturbances in patients with relapsing remitting multiple sclerosis.Q52113272
Cognitive impairment in patients with multiple sclerosis and mild physical disability.Q52256834
Defining the clinical course of multiple sclerosis: Results of an international surveyQ22241638
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)Q22241644
An Inventory for Measuring DepressionQ26778503
Cognitive dysfunction in multiple sclerosis: a review of recent developmentsQ28186881
Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 yearsQ28191390
Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and predictionQ28276538
Clinically isolated lesions of the type seen in multiple sclerosis: a cognitive, psychiatric, and MRI follow up studyQ33591681
Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.Q34253953
New diagnostic criteria for multiple sclerosis: guidelines for research protocolsQ34271601
Minimal neuropsychological assessment of MS patients: a consensus approachQ35073778
Speed of information processing as a key deficit in multiple sclerosis: implications for rehabilitationQ35453717
A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosisQ35462222
Neuropsychological deficits in multiple sclerosis after acute relapseQ36318073
The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration BatteryQ36836629
Neuropsychologic status in multiple sclerosis after treatment with glatiramerQ38450118
Neuropsychological aspects of multiple sclerosis: a quantitative reviewQ40864839
The prevalence of cognitive impairment in a community survey of multiple sclerosisQ41822037
Is speed of processing or working memory the primary information processing deficit in multiple sclerosis?Q44794717
Donepezil improved memory in multiple sclerosis in a randomized clinical trialQ45144727
Constructional apraxia in left brain-damaged patients: a planning disorder?Q48286491
Analysis of impairment related functional architecture in MS patients during performance of different attention tasksQ48332262
A modified card sorting test sensitive to frontal lobe defectsQ48346552
Speed of information processing in patients with multiple sclerosisQ48425874
P433issue1
P921main subjectmultiple sclerosisQ8277
cognitive dysfunctionQ57859955
relapsing-remitting multiple sclerosisQ18555066
P304page(s)77-87
P577publication date2006-02-01
P1433published inMultiple Sclerosis JournalQ1952449
P1476titleCognitive dysfunction in patients with relapsing-remitting multiple sclerosis
P478volume12